• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » Health care reform: Medicare overhaul isn’t settled yet

Health care reform: Medicare overhaul isn’t settled yet

May 26, 2011 By MassDevice staff

MassDevice On Call

MASSDEVICE ON CALL — Despite an electoral setback, Republicans aren’t backing down on their controversial plan to overhaul Medicare.

New York’s traditionally Republican district elected Democrat Kathy Hochul to the U.S. House. Republicans responded by vowing to renew their ardor for Medicare reform.

The Republican plan, authored by Rep. Paul Ryan (R.-Wis.), would transform Medicare into a voucher system for those under 55 years old.

Democrats countered by saying the Ryan plan would shift health care costs to seniors and people with disabilities. "[Democrats] are shamelessly demagoguing and distorting it," Ryan told the Wall Street Journal.

The measure, which passed the House, failed in the Senate on a 57-40 vote yesterday. No Democrats voted for the plan; five Republicans crossed the aisle to oppose it.

Research finds altered brain structure among autistic patients.

The temporal and frontal lobes of the brains of people with autism are more similar than those without the syndrome, according to a new study from UCLA.

Those two brain lobes are usually easy to discern, thanks to hundreds of genes that behave differently from region to region. The study considered the brains of 19 autistic patients, looking for patterns that might hint at the underlying mechanism of autism. The research is the first to reveal how the disorder works at the molecular level, altering brain structure through gene expression.

The findings support the theory that changes in the brain lead to autism, rather than the other way around, according to principal investigator Dr. Daniel Geschwind.

Medical Record Bank wins patent for online electronic medical record system

The U.S. Patent and Trademark Office issued a patent to Boston-based Medical Record Bank Inc. for a “patient-centric technology for medical record centralization.” The system allows patients and doctors to access patient-labeled and authenticated chronological medical histories, offers patient health care diaries and maintains critical health information summaries.

The system collects patient data from all healthcare providers the individual may be involved with, and allows the consumer to control their information with an interface that is "as easy to use as e-mail," according to a release.

Angiodynamics prepares for NanoKnife trials, cuts LC Bead distribution

After the Food & Drug Administration warned AngioDynamics Inc. (NSDQ:ANGO) for some allegedly over-zealous marketing of its NanoKnife system early this year, the company won IDE approval to test the device for the ablation of low-risk localized prostate cancer. The FDA’s approval is for a total of six patients at up to three sites in the U.S. to provide a basis for additional trials.

The Latham, N.Y.-based company also announced the expiration of its contract with BTG plc (LSE:BGC) for U.S. distribution of the LC Bead embolization device, which represented approximately 13 percent of AngioDynamics’ net sales through the first nine months of FY2011, according to a release.

Just do it: Covington senior counsel says FDA and 510(k) are flawed, but unavoidable

The FDA’s procedures may be frustrating, but there’s no way around them, senior counsel for Covington & Burling Peter Barton Hutt argued during a panel at the InHealth 510(k) Survey Results conference in D.C. yesterday.

Hutt, who counsels medical device makers on the regulatory labyrinth, broke his advice into two phases.

: "Step one, find out what FDA wants. Step two—do it. It doesn’t matter if what they ask for is stupid or brilliant. It doesn’t matter if the request is reasonable. If you don’t give FDA what they ask for, you aren’t going to get your device approved," said Hutt, who was seated immediately to the left of Dr. Jeffrey Shuren, head of the FDA’s medical deice arm.

Shuren said he liked Hutt’s Law, with one caveat: The FDA’s requests must be grounded in good science.

Filed Under: Healthcare Reform, News Well Tagged With: AngioDynamics, Clinical Trials, Medical Record Bank Inc.

In case you missed it

  • Boston Scientific to build new plant outside Atlanta
  • NovaXS unveils prototype for smart, needle-free drug delivery device
  • ResMed names Lucile Blaise as new Sleep & Respiratory Care leader
  • SpineX enrolls first patient in spinal neuromodulation technology trial
  • GE Healthcare’s Carescape ventilator battery recall is Class I
  • Cardinal Health starts Zipline drone deliveries of drugs and medical supplies
  • Advanced NanoTherapies closes $7.2M Series A for drug-coated balloon
  • Centerline Biomedical raises $33M Series B
  • How medical device companies are responding to abortion bans
  • Memic completes first robotic-assisted transvaginal hysterectomy procedures with Hominis
  • ‘Multiple disruptions’ slow timeline for Titan Medical’s Enos robotic surgery platform
  • Philips updates on testing results for recalled ventilators
  • Varian wins FDA IDE for Flash radiation therapy
  • Researchers develop wearable robotic exomuscle system
  • Virpax to pursue over-the-counter pathway for topical spray treatment for osteoarthritis pain
  • Inovio names new chief medical officer
  • FDA clears Acutus’ AcQCross system for use with Boston Scientific’s Watchman

RSS From Medical Design & Outsourcing

  • Philips updates on testing results for recalled ventilators
    Royal Philips (NYSE:PHG) says only a small portion of returned respiratory devices displayed the sound abatement foam degradation that sparked a massive recall. Repeated ozone cleaning may have made the problem worse. Those were some of the major takeaways from an update Philips provided today on a comprehensive test and research program it implemented after its… […]
  • ResMed names Lucile Blaise as new Sleep & Respiratory Care leader
    Lucile Blaise will be the new president of ResMed’s Sleep & Respiratory Care business starting July 1, ResMed (NYSE: RMD) said today. She replaces Jim Hollingshead, who became president and CEO of Insulet (Nasdaq:PODD) on June 1. ResMed President and COO Rob Douglas is serving as interim president of the Sleep & Respiratory Care during… […]
  • Cardinal Health starts Zipline drone deliveries of drugs and medical supplies
    Cardinal Health (NYSE: CAH) today started air delivery of pharmaceutical products and medical supplies via Zipline drone in North Carolina. San Francisco-based Zipline won FAA Part 135 air carrier certification for the long-range flights earlier this month. The company flew its first commercial deliveries on June 22 with an initial 16-nautical-mile flight. The flights starting… […]
  • How medical device companies are responding to abortion bans
    Days after the U.S. Supreme Court’s decision to overturn Roe v. Wade’s protection of abortion rights, medical device companies are among those reassuring workers about healthcare access. Corporate communications to employees and the public at large come as trigger laws in nearly half of the states outlaw abortion immediately. Some medtech companies are not using… […]
  • Boston Centerless opens manufacturing plant in Indiana
    Boston Centerless announced today that it opened a second manufacturing plant in Fort Wayne, Indiana. Woburn, Massachusetts-based Boston Centerless said in a news release that the latest expansion for the supplier of precision ground bar materials for close tolerance CNC Swiss machining applications represents continued robust growth in key market segments in the Midwest and… […]
  • Dymax strikes new partnership with Quantum Systems
    Rapid curing materials and equipment manufacturer Dymax today announced a new sales partnership with Quantum Systems. Torrington, Connecticut-based Dymax said in a news release that Quantum, with its offices in Arizona as well as Sonora and Baja, Mexico, will focus its efforts on promoting and supporting the sales of Dymax light-curing solutions to the medical,… […]
  • Researchers develop wearable robotic exomuscle system
    ETH Zurich researchers have redefined the muscle shirt. Marie Georgarakis, a former doctoral student at ETH Zurich’s Sensory Motor Systems Lab, is the creator of the Myoshirt, a wearable, textile robotic device that helps users lift their arms and reach. A motorized cable works like an artificial tendon, directed by sensors and an algorithm to… […]
  • They said it at DeviceTalks Boston
    Medtech insiders convened at DeviceTalks Boston 2022 in May to discuss device design, innovation and trends shaping the industry now and in the years and decades ahead. Here are some of the most quotable insights from panelists and speakers at our live event. And make sure to save the date — and save your seat… […]
  • Summer health technology program brings diverse group of interns to Silicon Valley
    Diversity by Doing HealthTech (DxD) is holding a Summer Innovation and Exploration Series for college student interns from underrepresented groups. The series is on its second day today at Fogarty Innovation and Stanford Byers Center for Biodesign — the two organizations that jointly formed and support DxD. The event debuted last year in an online… […]
  • Clippard releases new series of isolation valves
    Clippard (Cincinnati) has Its Clippard NIV Series media isolation valve — a solenoid-operated device using a flexible diaphragm to isolate the actuation mechanism from the fluid path. Media isolation valves find everyday use in a wide variety of applications. Think uses that require precise, repeatable dispensing of media for analytical instrumentation. Clippard says media isolation… […]
  • Another Medtronic HVAD recall is serious
    A year after Medtronic ceded the LVAD market to Abbott, it has yet another Class I recall involving HeartWare Ventricular Assist Device pumps still implanted in patients. The FDA today designated a Medtronic recall involving the HVADs as Class I, the most serious level. It’s the second Class I recall designation for the HVADs this… […]

Leave a Reply

You must be logged in to post a comment.

Primary Sidebar

DeviceTalks Weekly

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS